**MetroHealth Medical Center Discharge Summary**  **Patient:** [B-NAME]Helen Mitchell[O], MRN# [B-ID]4748265[O]  **Age:** [B-AGE]68 years[O]  **Admission Date:** [B-DATE]January 22nd, 2023[O]     **Discharge Date:** [B-DATE]February 5th, 2023[O]  **Admitting Physician:** Dr. [B-NAME]Emily Stanton[O]     **Attending Physician:** Dr. [B-NAME]Emily Stanton[O]  **Consultants:** Cardiology, Nephrology     **Discharge NP/PA:** [B-NAME]Jessica Bosch[O], PA-C  **Referring Physician/Cardiologist:** [B-NAME]Aaron Lee[O], MD     **Primary Care Physician (PCP):** Dr. [B-NAME]Ian Frederick[O], MD, [B-ADDRESS]742 Evergreen Terrace, Springfield, IL 62701[O]  **Hospital Problems Noted - Resolved POA Active Problems:** - Atrial fibrillation ([B-DATE]January 23rd, 2023[O] - Present) - Chronic Kidney Disease Stage 3 ([B-DATE]January 24th, 2023[O] - Present) - Hypertension ([B-DATE]January 22nd, 2023[O] - Present)  **Other Problems:** - None  **Brief Hospital Course:** - [B-NAME]Helen Mitchell[O] was admitted following a syncopal episode at home. She presented with atrial fibrillation with rapid ventricular response and was subsequently cardioverted to normal sinus rhythm. Her stay was complicated by acute on chronic kidney injury, likely precipitated by dehydration and pre-existing CKD. - Patient responded well to IV fluid resuscitation and rate control using beta-blockers. Echocardiography showed preserved ejection fraction and no significant valvular disease.  - Renal function stabilized with conservative management, including adjustment of her home medications. - Throughout her stay, patient was monitored continuously, showing no further episodes of arrhythmia post-cardioversion.  **Medications on Discharge:** 1. Metoprolol Succinate 50 mg daily 2. Apixaban 5 mg BID 3. Lisinopril 10 mg daily 4. Multivitamin 1 daily  **Discharge Condition:** - Stable  **Disposition:** Home  **Instructions:** - Continue medications as prescribed. - Follow up with PCP, Dr. [B-NAME]Ian Frederick[O] within one week for blood pressure and kidney function recheck. - Cardiology follow-up in two weeks with Dr. [B-NAME]Aaron Lee[O]. - Monitor for signs of bleeding while on Apixaban. Contact your doctor if you experience any unusual bruising or bleeding.  **Follow-Up Appointments:** - [B-DATE]February 12th, 2023[O] at 10:00 AM with Dr. [B-NAME]Ian Frederick[O], [B-ORGANIZATION]Springfield Internal Medicine Clinic[O].  - [B-DATE]February 19th, 2023[O] at 2:30 PM with Dr. [B-NAME]Aaron Lee[O], [B-ORGANIZATION]MetroHeart Cardiology Group[O], [B-LOCATION]Outpatient Building, Room 205[O].  **Instructions for Patient's Family:** - Ensure the patient takes her medications as prescribed. - Assist patient maintaining a log of blood pressure readings twice daily. - Ensure adequate fluid intake.  **Dietary Instructions:** - Maintain a low-salt diet. - Moderate fluid intake as per renal guidelines.  **Physical Activity:** - Gradual return to regular activities as tolerated. - Avoid heavy lifting and strenuous exercise until the follow-up appointment with the cardiologist.  **Signed:**     Dr. [B-NAME]Emily Stanton[O], MD, [B-DATE]February 5th, 2023[O], 4:30 PM  ---  This discharge summary follows the standard format presenting key details including PHI appropriately labeled, ensuring patient privacy while providing a complete clinical picture for follow-up providers. 